Candida Infections Drugs - Global and China Top Players Market Share and Ranking 2023
According to the latest research analysis,the global market for Candida Infections Drugs should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Candida Infections Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Candida Infections Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Beriberi grew percent to account for percent of the total market sales, and Jock Itch grew percent.
Candida infection is a yeast infection where the skin acts as a host organism, and the infection multiplies and grows with the period. Candida albicans are the most common species of this infection. Candida normally lives on the skin and inside the body, such as the throat, gut, mouth, and vagina, without causing problems. It can cause infections if it grows out of control or enters deep into the body.
This report studies and analyses global Candida Infections Drugs status and future trends, helps the client to determine the Candida Infections Drugs market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Candida Infections Drugs, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Candida Infections Drugs market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Candida Infections Drugs sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Candida Infections Drugs sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Candida Infections Drugs key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Candida Infections Drugs key producing regions, capacity, production, and year over year growth
(6) Candida Infections Drugs industry chains, upstream, midstream and downstream
Understanding Market Segments by Key Players: Insights and Opportunities
F. Hoffmann-La Roche Ltd
Mylan NV
Teva Pharmaceutical Industries Ltd
Sanofi
Pfizer Inc
GSK plc
Novartis AG
AstraZeneca
Johnson & Johnson Private Limited
Sun Pharmaceutical Industries Ltd
Merck & Co., Inc
Bristol-Myers Squibb Company
Lilly
Amgen Inc
Understanding Market Segments by Type: A Comparative Analysis
Azole
Nystatin
Other
Market Segmentation by Application: Dividing Key Markets and Identifying Opportunities
Beriberi
Jock Itch
Vaginal Infection
Other
Breaking Down Market Segments by Region: A Deep Dive Analysis
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Uncovering Market Potential: What Our Report Includes
Chapter 1: to describe Candida Infections Drugs product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Candida Infections Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Candida Infections Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Candida Infections Drugs, percent & CAGR, 2018-2029
Chapter 5: Candida Infections Drugs industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Candida Infections Drugs Definition
1.2 Global Candida Infections Drugs Market Size and Forecast
1.2.1 By Consumption Value, Global Candida Infections Drugs Market Size，2018-2029
1.2.2 By Sales Quantity, Global Candida Infections Drugs Market Size，2018-2029
1.2.3 Global Candida Infections Drugs Average Selling Price (ASP)，2018-2029
1.3 China Candida Infections Drugs Market Size and Forecast
1.3.1 By Consumption Value, China Candida Infections Drugs Market Size，2018-2029
1.3.2 By Sales Quantity, China Candida Infections Drugs Market Size，2018-2029
1.3.3 China Candida Infections Drugs Average Selling Price (ASP)， 2018-2029
1.4 Share of China Candida Infections Drugs Market with Respect to the Global Market
1.4.1 By Consumption Value, China Candida Infections Drugs Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Candida Infections Drugs Market Share in Global, 2018-2029
1.4.3 Candida Infections Drugs Market Size: China VS Global, 2018-2029
1.5 Candida Infections Drugs Market Dynamics
1.5.1 Candida Infections Drugs Market Drivers
1.5.2 Candida Infections Drugs Market Restraints
1.5.3 Candida Infections Drugs Industry Trends
1.5.4 Candida Infections Drugs Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Candida Infections Drugs, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Candida Infections Drugs, Global Market Share by Company, 2018-2023
2.3 Candida Infections Drugs Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Candida Infections Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Candida Infections Drugs Concentration Ratio
2.6 Global Candida Infections Drugs Mergers & Acquisitions, Expansion Plans
2.7 Global Candida Infections Drugs Manufacturers Product Type
2.8 Head Office and Candida Infections Drugs Production Site of Key Manufacturer
2.9 Candida Infections Drugs Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Candida Infections Drugs, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Candida Infections Drugs, China Market Share by Company, 2018-2023
3.3 China Candida Infections Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Candida Infections Drugs Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Candida Infections Drugs Capacity by Region
4.3 Global Candida Infections Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Candida Infections Drugs Production by Region, 2018-2029
4.5 Global Candida Infections Drugs Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Candida Infections Drugs Industry Chain
5.2 Candida Infections Drugs Upstream Analysis
5.2.1 Candida Infections Drugs Core Raw Materials
5.2.2 Main Manufacturers of Candida Infections Drugs Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Candida Infections Drugs Production Mode
5.6 Candida Infections Drugs Procurement Model
5.7 Candida Infections Drugs Industry Sales Model and Sales Channels
5.7.1 Candida Infections Drugs Sales Model
5.7.2 Candida Infections Drugs Typical Distributors
6 Sights by Type
6.1 Candida Infections Drugs Classification
6.1.1 Azole
6.1.2 Nystatin
6.1.3 Other
6.2 By Type, Global Candida Infections Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Candida Infections Drugs Consumption Value, 2018-2029
6.4 By Type, Global Candida Infections Drugs Sales Quantity, 2018-2029
6.5 By Type, Global Candida Infections Drugs Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Candida Infections Drugs Segment by Application
7.1.1 Beriberi
7.1.2 Jock Itch
7.1.3 Vaginal Infection
7.1.4 Other
7.2 By Application, Global Candida Infections Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Candida Infections Drugs Consumption Value, 2018-2029
7.4 By Application, Global Candida Infections Drugs Sales Quantity, 2018-2029
7.5 By Application, Global Candida Infections Drugs Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Candida Infections Drugs Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Candida Infections Drugs Consumption Value, 2018-2029
8.3 By Region, Global Candida Infections Drugs Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Candida Infections Drugs & Forecasts, 2018-2029
8.4.2 By Country, North America Candida Infections Drugs Market Size Market Share
8.5 Europe
8.5.1 Europe Candida Infections Drugs Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Candida Infections Drugs Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Candida Infections Drugs Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Candida Infections Drugs Market Size Market Share
8.7 South America
8.7.1 South America Candida Infections Drugs Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Candida Infections Drugs Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Candida Infections Drugs Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Candida Infections Drugs Consumption Value, 2018-2029
9.3 By Country, Global Candida Infections Drugs Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Candida Infections Drugs Market Size, 2018-2029
9.4.2 By Type, U.S. Candida Infections Drugs Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Candida Infections Drugs Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Candida Infections Drugs Market Size, 2018-2029
9.5.2 By Type, Europe Candida Infections Drugs Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Candida Infections Drugs Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Candida Infections Drugs Market Size, 2018-2029
9.6.2 By Type, China Candida Infections Drugs Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Candida Infections Drugs Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Candida Infections Drugs Market Size, 2018-2029
9.7.2 By Type, Japan Candida Infections Drugs Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Candida Infections Drugs Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Candida Infections Drugs Market Size, 2018-2029
9.8.2 By Type, South Korea Candida Infections Drugs Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Candida Infections Drugs Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Candida Infections Drugs Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Candida Infections Drugs Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Candida Infections Drugs Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Candida Infections Drugs Market Size, 2018-2029
9.10.2 By Type, India Candida Infections Drugs Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Candida Infections Drugs Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Candida Infections Drugs Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Candida Infections Drugs Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Candida Infections Drugs Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 F. Hoffmann-La Roche Ltd
10.1.1 F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area, and Industry Position
10.1.2 F. Hoffmann-La Roche Ltd Candida Infections Drugs Models, Specifications, and Application
10.1.3 F. Hoffmann-La Roche Ltd Candida Infections Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 F. Hoffmann-La Roche Ltd Company Profile and Main Business
10.1.5 F. Hoffmann-La Roche Ltd Recent Developments
10.2 Mylan NV
10.2.1 Mylan NV Company Information, Head Office, Market Area, and Industry Position
10.2.2 Mylan NV Candida Infections Drugs Models, Specifications, and Application
10.2.3 Mylan NV Candida Infections Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Mylan NV Company Profile and Main Business
10.2.5 Mylan NV Recent Developments
10.3 Teva Pharmaceutical Industries Ltd
10.3.1 Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area, and Industry Position
10.3.2 Teva Pharmaceutical Industries Ltd Candida Infections Drugs Models, Specifications, and Application
10.3.3 Teva Pharmaceutical Industries Ltd Candida Infections Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Teva Pharmaceutical Industries Ltd Company Profile and Main Business
10.3.5 Teva Pharmaceutical Industries Ltd Recent Developments
10.4 Sanofi
10.4.1 Sanofi Company Information, Head Office, Market Area, and Industry Position
10.4.2 Sanofi Candida Infections Drugs Models, Specifications, and Application
10.4.3 Sanofi Candida Infections Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Sanofi Company Profile and Main Business
10.4.5 Sanofi Recent Developments
10.5 Pfizer Inc
10.5.1 Pfizer Inc Company Information, Head Office, Market Area, and Industry Position
10.5.2 Pfizer Inc Candida Infections Drugs Models, Specifications, and Application
10.5.3 Pfizer Inc Candida Infections Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Pfizer Inc Company Profile and Main Business
10.5.5 Pfizer Inc Recent Developments
10.6 GSK plc
10.6.1 GSK plc Company Information, Head Office, Market Area, and Industry Position
10.6.2 GSK plc Candida Infections Drugs Models, Specifications, and Application
10.6.3 GSK plc Candida Infections Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 GSK plc Company Profile and Main Business
10.6.5 GSK plc Recent Developments
10.7 Novartis AG
10.7.1 Novartis AG Company Information, Head Office, Market Area, and Industry Position
10.7.2 Novartis AG Candida Infections Drugs Models, Specifications, and Application
10.7.3 Novartis AG Candida Infections Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Novartis AG Company Profile and Main Business
10.7.5 Novartis AG Recent Developments
10.8 AstraZeneca
10.8.1 AstraZeneca Company Information, Head Office, Market Area, and Industry Position
10.8.2 AstraZeneca Candida Infections Drugs Models, Specifications, and Application
10.8.3 AstraZeneca Candida Infections Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 AstraZeneca Company Profile and Main Business
10.8.5 AstraZeneca Recent Developments
10.9 Johnson & Johnson Private Limited
10.9.1 Johnson & Johnson Private Limited Company Information, Head Office, Market Area, and Industry Position
10.9.2 Johnson & Johnson Private Limited Candida Infections Drugs Models, Specifications, and Application
10.9.3 Johnson & Johnson Private Limited Candida Infections Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Johnson & Johnson Private Limited Company Profile and Main Business
10.9.5 Johnson & Johnson Private Limited Recent Developments
10.10 Sun Pharmaceutical Industries Ltd
10.10.1 Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area, and Industry Position
10.10.2 Sun Pharmaceutical Industries Ltd Candida Infections Drugs Models, Specifications, and Application
10.10.3 Sun Pharmaceutical Industries Ltd Candida Infections Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Sun Pharmaceutical Industries Ltd Company Profile and Main Business
10.10.5 Sun Pharmaceutical Industries Ltd Recent Developments
10.11 Merck & Co., Inc
10.11.1 Merck & Co., Inc Company Information, Head Office, Market Area, and Industry Position
10.11.2 Merck & Co., Inc Candida Infections Drugs Models, Specifications, and Application
10.11.3 Merck & Co., Inc Candida Infections Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Merck & Co., Inc Company Profile and Main Business
10.11.5 Merck & Co., Inc Recent Developments
10.12 Bristol-Myers Squibb Company
10.12.1 Bristol-Myers Squibb Company Company Information, Head Office, Market Area, and Industry Position
10.12.2 Bristol-Myers Squibb Company Candida Infections Drugs Models, Specifications, and Application
10.12.3 Bristol-Myers Squibb Company Candida Infections Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Bristol-Myers Squibb Company Company Profile and Main Business
10.12.5 Bristol-Myers Squibb Company Recent Developments
10.13 Lilly
10.13.1 Lilly Company Information, Head Office, Market Area, and Industry Position
10.13.2 Lilly Candida Infections Drugs Models, Specifications, and Application
10.13.3 Lilly Candida Infections Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Lilly Company Profile and Main Business
10.13.5 Lilly Recent Developments
10.14 Amgen Inc
10.14.1 Amgen Inc Company Information, Head Office, Market Area, and Industry Position
10.14.2 Amgen Inc Candida Infections Drugs Models, Specifications, and Application
10.14.3 Amgen Inc Candida Infections Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Amgen Inc Company Profile and Main Business
10.14.5 Amgen Inc Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|